Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2021-12-03 00:00:00 ET · period of report 2021-12-02 · accession 0001209191-21-067954 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-03 | 2021-12-02 | KPTI | Mitchener Stephen | SVP, Chief Business Off | S - Sale | $6.69 | -499 | 3,296 | -13% | -$3,338 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-02 | S | D | 499 | $6.69 | 3,296 | D | — | — | (F2) Includes 1,323 shares acquired by the reporting person under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on October 31, 2021. |